This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment and prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Surgery is indicated for all symptomatic para-oesophageal hernia particularly those with acute obstructive symptoms or which have undergone volvulus

  • in majority of cases there is severe anatomical distortion making laproscopic repair a complex operation
  • hernia sac is completely resected from the mediastinum, oesophagus is mobilized, hiatus is closed (sometimes using mesh), and fundoplication
  • the risk of surgery must be balanced against the underlying risk of complications from paraesophageal hernia before considering surgery (1,2)

Routine elective repair may not be necessary in completely asymptomatic paraesophageal hernias. Patient’s age and co-morbidities should be taken into account before surgery (1,2)

  • progression from asymptomatic to symptomatic paraesophageal hernia is thought to be around 14% per year
  • the risk of developing acute symptoms that require emergency surgery is less than 2%

If strangulation has already taken place, emergency gastric resection is required.

Recurrence rate for paraesophageal hernia after repair is up to 50% at five years (2).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.